Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan · Delayed Price · Currency is TWD 29.95
+0.45 (1.53%)
At close: Jan 19, 2026
Formosa Pharmaceuticals Revenue
Formosa Pharmaceuticals had revenue of 911.00K TWD in the quarter ending September 30, 2025, a decrease of -78.98%. This brings the company's revenue in the last twelve months to 12.16M, down -91.15% year-over-year. In the year 2024, Formosa Pharmaceuticals had annual revenue of 143.36M with 359.89% growth.
Revenue (ttm)
12.16M
Revenue Growth
-91.15%
P/S Ratio
363.67
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 143.36M | 112.18M | 359.89% |
| Dec 31, 2023 | 31.17M | 29.86M | 2,270.49% |
| Dec 31, 2022 | 1.32M | -27.21M | -95.39% |
| Dec 31, 2021 | 28.53M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |
| Caliway Biopharmaceuticals | 34.99M |